Country: Awstralja
Lingwa: Ingliż
Sors: APVMA (Australian Pesticides and Veterinary Medicines Authority)
TRIMETHOPRIM; SULFADOXINE
JUROX PTY LIMITED
PARENTERAL LIQUID/SOLUTION/SUSPENSION
TRIMETHOPRIM PYRIMIDINE Active 40.0 mg/ml; SULFADOXINE SULFANYL Active 200.0 mg/ml
100 mL
VM - Veterinary Medicine
ANTIBIOTIC & RELATED
Poison schedule: 4; Withholding period: MEAT: (CATTLE, SHEEP, PIGS): DO NOT USE less than 14 days before slaughter for h uman consumption. (HORSES): DO NOT USE l ess than 28 days before slaughter for hu man consumption. MILK: Milk collected from cows and ewes within 36 hours (3 m ilkings) following a single treatment or 72 hours (6 milkings) following the las t of multiple treatments, MUST NOT BE US ED or processed for human consumption, o r fed to bobby calves. Any variation by the prescribing veterinarian to the a pproved dose, frequency, duration, route , disease or target species may result i n the need to extend the approved withho lding period. An ESI has not been estab lished for this product. Note - observi ng the meat withholding period may not b e sufficient to mitigate potential risks to export trade. Trade advice should be sought from Jurox Pty Limited on 1800 0 23 312 before using the product.; Host/pest details: CAT: [ORGANISMS SENSITIVE TO SULFADOXINE, ORGANISMS SENSITIVE TO TRIMETHOPRIM]; CATTLE: [ORGANISMS SENSITIVE TO SULFADOXINE, ORGANISMS SENSITIVE TO TRIMETHOPRIM]; DOG: [ORGANISMS SENSITIVE TO SULFADOXINE, ORGANISMS SENSITIVE TO TRIMETHOPRIM]; HORSE: [ORGANISMS SENSITIVE TO SULFADOXINE, ORGANISMS SENSITIVE TO TRIMETHOPRIM]; PIGS: [ORGANISMS SENSITIVE TO SULFADOXINE, ORGANISMS SENSITIVE TO TRIMETHOPRIM]; SHEEP: [ORGANISMS SENSITIVE TO SULFADOXINE, ORGANISMS SENSITIVE TO TRIMETHOPRIM]
Registered
2023-07-01
JUROX TMPS ANTIBACTERIAL SOLUTION FOR INJECTION 89895/126306 Product Name: APVMA Approval No: Label Name: JUROX TMPS ANTIBACTERIAL SOLUTION FOR INJECTION Signal Headings: PRESCRIPTION ANIMAL REMEDY KEEP OUT OF REACH OF CHILDREN FOR ANIMAL TREATMENT ONLY Constituent Statements: 200 mg/mL SULFADOXINE 40 mg/mL TRIMETHOPRIM Claims: Jurox TMPS Antibacterial Solution for Injection contains 40 mg/mL trimethoprim, a synthetic antibacterial developed in the Wellcome Research Laboratories, and 200 mg/mL sulfadoxine, a long acting sulfonamide. Jurox TMPS Antibacterial Solution for Injection is effective against most Gram-positive and Gram-negative bacteria. The two components of Jurox TMPS Antibacterial Solution for Injection produce a sequential double blockade of bacterial metabolism giving a level of activity many times greater than that obtained from either drug alone. For the treatment of infections caused by organisms sensitive to trimethoprim and sulfadoxine in cattle, sheep, pigs, horses, cats and dogs. Jurox TMPS Antibacterial Solution for Injection is indicated for the systemic treatment of: Respiratory infections of bacterial origin including pneumonia, bronchitis and secondary bacterial infections following virus pneumonia. Urogenital tract infections including cystitis, vaginitis, urethritis, nephritis and metritis. Alimentary tract infections including Escherichia coli infections and salmonellosis. Other infections, such as foul-in-the-foot, severe mastitis, bacterial agalactia of sows, post- operative and post-parturient uses, wound infections and septicaemias. Jurox TMPS Antibacterial Solution for Injection is active in vitro against Gram-positive and Gram-negative organisms including Actinomyces spp., Bacillus anthracis, Bordetella spp., Brucella spp., Clostridium spp., Corynebacterium spp., E. coli, Haemophilus spp., Klebsiella spp., Shigella spp., Staphylococci, Streptococci, Pasteurella spp., Salmonella spp., Fusiformis spp., and Campylobacter spp. Note: Erysipelothrix, Leptospira and Pseudomonas organis Aqra d-dokument sħiħ